中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

77 records (took 0.026 seconds)

    Pyrazolopyrimidine compounds
    14.
    发明专利
    Pyrazolopyrimidine compounds 未知

    公开(公告)号：NZ707432A

    公开(公告)日：2020-01-31

    申请号：NZ70743213

    申请日：2013-11-15

    Applicant: UNIV HEALTH NETWORK

    Inventor： LIU YONG ,  PAULS HEINZ W ,  LAUFER RADOSLAW ,  LI SZE-WAN ,  SAMPSON PETER BRENT ,  FEHER MIKLOS ,  NG GRACE ,  PATEL NARENDRA KUMAR B ,  LANG YUNHUI

    IPC: C07D487/04 ,  A61K31/519 ,  A61P35/00

    Abstract: The present teachings provide a compound represented by structural formula (II-A0), or a pharmaceutically acceptable salt thereof. R1 is –NHRb1, where Rb1 is alkyl which may be optionally substituted with one or more groups as defined herein. R2 is optionally substituted heterocycloalkyl, heteroaryl, optionally substituted aryloxy, optionally substituted heteroaryloxy, optionally substituted heterocyclyloxy or substituted amino (and wherein the substituents are as defined herein). R4 is chloro or methyl. Rd is cyclopropyl. Specific compounds include N-cyclopropyl-4-(7-(((trans-3-hydroxy-3-methylcyclobutyl)methyl)amino)-5-(pyridin-3-yloxy)pyrazolo[1,5-a]pyrimidin-3-yl)-2-methylbenzamide (CFI-402257) and N-cyclopropyl-4-(7-((cyclopropylmethyl)amino)-5-(((1S,2R)-2-hydroxycyclohexyl)amino)pyrazolo[1,5-a]pyrimidin-3-yl)-2-methylbenzamide. Also described are pharmaceutical compositions and uses thereof, such as for the inhibitors of tyrosine threonine kinase (TTK) and for the treatment of cancers such as pancreatic cancer, prostate cancer, lung cancer, melanoma, breast cancer, colon cancer, or ovarian cancer.

Patent Agency Ranking